During the past decade, Toronto Liver Centre conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 30 clinical trials were completed, i.e. on average, 88.2% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 22 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toronto Liver Centre" #1 sponsor was "Gilead Sciences" with 22 trials, followed by "Celgene" with 3 trials sponsored, "Allergan" with 2 trials sponsored, "Assembly Biosciences" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toronto Liver Centre" #1 collaborator was "Arbutus Biopharma Corporation" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Novo Nordisk A/S" with 1 trials as a collaborator and "Triangle Biostatistics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Toronto Liver Centre" are "Chronic Hepatitis B" (6 trials), "Nonalcoholic Steatohepatitis" (5 trials), "Chronic Hepatitis C" (4 trials), "Ulcerative Colitis" (4 trials) and "Cirrhosis" (2 trials). Many other conditions were trialed in "Toronto Liver Centre" in a lesser frequency.

Most popular intervention types in "Toronto Liver Centre" are "Drug" (44 trials), "Biological" (6 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "RBV" (6 trials), "TAF" (4 trials), "SEL" (3 trials) and "SIM" (3 trials). Other intervention names were less common.

The vast majority of trials in "Toronto Liver Centre" are 50 trials for "All" genders.

Currently, there are NaN active trials in "Toronto Liver Centre". undefined are not yet recruiting, 3 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Toronto Liver Centre, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Toronto Liver Centre, 0 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".